Eugene Pacelli Mccague net worth and biography

Eugene Mccague Biography and Net Worth

Director of Icon

Mr. Eugene McCague was appointed as a Non-Executive Director of ICON plc in October 2017.

Mr. McCague was a corporate partner of Arthur Cox, one of Ireland’s premier law firms, from 1988 until June 2017. During his time with Arthur Cox, Mr. McCague served as both managing partner and Chair of Arthur Cox and also advised a wide range of public and private companies on mainstream corporate work, mergers and acquisitions, corporate restructurings and corporate governance. In addition to his distinguished legal career, Mr. McCague also has extensive board experience with commercial, government and educational organizations.

Mr. McCague currently serves on the board of the Irish branch of AON Insurance. Mr. McCague’s previous board roles include the Health Service Executive, the Irish state body which administers public health service in Ireland, Chair of the governing body of the Dublin Institute of Technology, Chair of the Dublin Institute of Technology Foundation and Chair of the governing authority of University College Dublin and Director of Fly Leasing Limited and Chair of Ibec, Ireland's leading business representative association. Mr. McCague was also president of the Dublin Chamber of Commerce in 2006.

Mr. McCague holds a Bachelor of Civil Law degree and a diploma in European Law from University College Dublin.

What is Eugene Pacelli Mccague's net worth?: The estimated net worth of Eugene Pacelli Mccague is at least $642.75 thousand as of August 11th, 2026. Mccague owns 3,811 shares of Icon stock worth more than $642,748 as of August 17th. This net worth evaluation does not reflect any other assets that Mccague may own. Learn More about Eugene Pacelli Mccague's net worth.
How do I contact Eugene Pacelli Mccague?: The corporate mailing address for Mccague and other Icon executives is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. Icon can also be reached via phone at (531) 291-2000. Learn More on Eugene Pacelli Mccague's contact information.
Has Eugene Pacelli Mccague been buying or selling shares of Icon?: Over the course of the past ninety days, Eugene Pacelli Mccague has sold $138,167.89 of Icon stock. Most recently, Eugene Pacelli Mccague sold 841 shares of the business's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $164.29, for a transaction totalling $138,167.89. Following the completion of the sale, the director now directly owns 3,811 shares of the company's stock, valued at $626,109.19. Learn More on Eugene Pacelli Mccague's trading history.
Who are Icon's active insiders?: Icon's insider roster includes Barry Balfe (CEO), Brennan Brendan (CFO), John Climax (Director), Eugene Mccague (Director), Ciaran Murray (Director), and Anne Whitaker (Director). Learn More on Icon's active insiders.
Are insiders buying or selling shares of Icon?: In the last year, insiders at the medical research company sold shares 8 times. They sold a total of 9,531 shares worth more than $1,565,763.95. The most recent insider tranaction occured on August, 11th when Director Linda Grais sold 841 shares worth more than $138,167.89. Insiders at Icon own 44.0% of the company. Learn More about insider trades at Icon.
Information on this page was last updated on 8/11/2026.

Eugene Pacelli Mccague Insider Trading History at Icon

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/11/2026	Sell	841	$164.29	$138,167.89	3,811

Eugene Pacelli Mccague Buying and Selling Activity at Icon

Icon Company Overview

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Today's Range

Now: $168.34

$161.16

$169.37

50 Day Range

MA: $162.50

$140.73

$180.24

2 Week Range

Now: $168.34

$66.57

$203.91

Volume

232,559 shs

Average Volume

1,364,698 shs

Market Capitalization

$12.89 billion

P/E Ratio

39.52

Dividend Yield

N/A

Beta

1.21